Response to 'How we define hyponatremia?'.
Royal Sussex County Hospital, Brighton, UK.
P
P
Grant
Department of Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Birmingham, UK.
J
J
Ayuk
Diabetes and Endocrinology, Royal Free London NHS Foundation Trust, London, UK.
P-M
PM
Bouloux
Diabetes and Endocrinology, Royal Free London NHS Foundation Trust, London, UK.
M
M
Cohen
Diabetes and Endocrinology, Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital, Hampshire, UK.
I
I
Cranston
Department of Diabetes and Endocrinology, Leeds Teaching Hospitals NHS Trust, St James's University Hospital, Leeds, UK.
R D
RD
Murray
Department of Endocrinology and Diabetes, Cardiff University School of Medicine, Cardiff, UK.
A
A
Rees
Department of Medical Oncology, Christie Hospital, NHS Trust Manchester, Manchester, UK.
N
N
Thatcher
Department of Endocrinology, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, University of Oxford, Oxford, UK.
A
A
Grossman
D000465:Algorithms; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D065092:Antidiuretic Hormone Receptor Antagonists / Q000627:therapeutic use*; D001552:Benzazepines / Q000627:therapeutic use*; D003707:Demeclocycline / Q000627:therapeutic use*; D005440:Fluid Therapy; D006801:Humans; D007010:Hyponatremia / Q000628:therapy*; D007177:Inappropriate ADH Syndrome / Q000628:therapy*
D000900:Anti-Bacterial Agents; D065092:Antidiuretic Hormone Receptor Antagonists; D001552:Benzazepines; D003707:Demeclocycline